CVS Health Corp (CVS) : Highland Capital Management reduced its stake in CVS Health Corp by 2.4% during the most recent quarter end. The investment management company now holds a total of 182,476 shares of CVS Health Corp which is valued at $17,700,172 after selling 4,493 shares in CVS Health Corp , the firm said in a disclosure report filed with the SEC on Jul 18, 2016.CVS Health Corp makes up approximately 1.48% of Highland Capital Management’s portfolio.
Other Hedge Funds, Including , Trust Co Of Vermont boosted its stake in CVS in the latest quarter, The investment management firm added 2,302 additional shares and now holds a total of 38,778 shares of CVS Health Corp which is valued at $3,761,466. CVS Health Corp makes up approx 0.49% of Trust Co Of Vermont’s portfolio.James Investment Research Inc reduced its stake in CVS by selling 6,070 shares or 4.74% in the most recent quarter. The Hedge Fund company now holds 121,871 shares of CVS which is valued at $11,805,644. CVS Health Corp makes up approx 0.29% of James Investment Research Inc’s portfolio.Balasa Dinverno Foltz reduced its stake in CVS by selling 165 shares or 2.18% in the most recent quarter. The Hedge Fund company now holds 7,401 shares of CVS which is valued at $716,935. CVS Health Corp makes up approx 0.13% of Balasa Dinverno Foltz’s portfolio.Central Bank Trust Co reduced its stake in CVS by selling 3,418 shares or 4.77% in the most recent quarter. The Hedge Fund company now holds 68,231 shares of CVS which is valued at $6,661,393. CVS Health Corp makes up approx 1.88% of Central Bank Trust Co’s portfolio.Daiwa Sb Investments Ltd. reduced its stake in CVS by selling 3,570 shares or 26.7% in the most recent quarter. The Hedge Fund company now holds 9,800 shares of CVS which is valued at $948,052. CVS Health Corp makes up approx 0.27% of Daiwa Sb Investments Ltd.’s portfolio.
CVS Health Corp opened for trading at $97.26 and hit $97.37 on the upside on Wednesday, eventually ending the session at $97, with a gain of 0.10% or 0.1 points. The heightened volatility saw the trading volume jump to 34,85,961 shares. Company has a market cap of $104,180 M.
On the company’s financial health, CVS Health Corp reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on May 3, 2016. Analyst had a consensus of $1.16. The company had revenue of $43215.00 million for the quarter, compared to analysts expectations of $43000.77 million. The company’s revenue was up 18.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS.
Many Wall Street Analysts have commented on CVS Health Corp. Shares were Reiterated by Mizuho on Jun 23, 2016 to “Buy” and Lowered the Price Target to $ 108 from a previous price target of $117 .Shares were Reiterated by Deutsche Bank on Jun 22, 2016 to “Hold” and Lowered the Price Target to $ 99 from a previous price target of $105 .CVS Health Corp was Downgraded by Morgan Stanley to ” Equal-Weight” on Jun 20, 2016.
CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.